Guilherme F. Attizzani

Jul 10, 2023 | jacc.org | Timothy B. Byrne |Syed Zaid |Guilherme F. Attizzani |Parasuram Krishnamoorthy

JACC Journals › JACC: Interventions › Archives › Vol. 16 No. 13 AbstractBackgroundThe latest-generation Evolut FX TAVR system (Medtronic) offers several potential design improvements over its predecessors, but early reported experience has been limited. ObjectivesThis study sought to report our multicenter, limited market release, first-in-human experience of transcatheter aortic valve replacement (TAVR) with the Evolut FX system and compare it with a single-center PRO+ (Medtronic) experience.